Table 2.
Independent all-cause mortality risk predictors in patients with stable CAD using the (a) NCEP and (b) IDF MetS definition
| Adjusted HR | 95% CI for upper | P value | |
|---|---|---|---|
| (a) Hazard ration among the NCEP metabolic group | |||
| Metabolic NCEP | 1.21 | 1.14–1.29 | <0.001 |
| Age >65 years | 1.08 | 1.07–1.08 | <0.001 |
| Male gender | 1.19 | 1.09–1.31 | <0.001 |
| Creatinine >1.5 mg/dL | 1.59 | 1.38–1.84 | <0.001 |
| Diabetes mellitus | 1.61 | 1.49–1.74 | <0.001 |
| Hypertension | 1.08 | 1.01–1.15 | 0.01 |
| Past MI | 1.41 | 1.31–1.52 | <0.001 |
| Previous CVA | 1.07 | 0.83–1.39 | 0.59 |
| NYHA >2 | 1.25 | 1.10–1.43 | <0.001 |
| Active smoker | 1.57 | 1.43–1.71 | <0.001 |
| (b) Hazard ration among the IDF metabolic group | |||
| Metabolic IDF | 1.17 | 1.07–1.28 | <0.001 |
| Age >65 years | 1.08 | 1.08–1.09 | <0.001 |
| Male gender | 1.17 | 1.06–1.29 | <0.001 |
| Creatinine >1.5 mg/dL | 1.60 | 1.38–1.84 | <0.001 |
| Diabetes mellitus | 1.68 | 1.56–1.81 | <0.001 |
| Hypertension | 1.10 | 1.04–1.18 | 0.003 |
| Past MI | 1.41 | 1.31–1.52 | <0.001 |
| Previous CVA | 1.10 | 0.85–1.42 | 0.48 |
| NYHA >2 | 1.23 | 1.07–1.41 | 0.003 |
| Active smoker | 1.57 | 1.43–1.72 | <0.001 |
Both models further adjusted for: hypertension, smoking status, and severe heart failure (NYHA >2)
CI 95% confidence interval; CVA cerebral-vascular accident; HR hazard ratio; MI myocardial infarction; NCEP National Cholesterol Education Program; IDF International Diabetes Federation; NYHA New York Heart Association